This letter represents the core of our mission.
Our letter formally presents new and credible medical evidence and sets out the lawful basis requiring the Government of Canada to reopen its investigation into Morgellons disease.
Rather than relying on protest or persuasion, this approach is grounded in evidence, statutory authority, and international legal obligations. It marks the first public step in a disciplined, lawful process aimed at securing recognition, accountability, and an appropriate public health response.
The following letter was sent by the Founder of Morgellons United to the Conservative Party of Canada’s Shadow Minister of Health, Dr. Steven Ellis, requesting formal review and onward transmission to the Federal Minister of Health.
Subject: Request for Review of New Medical Evidence and Reopening of PHAC Investigation into Morgellons Disease
To: The Honourable Dr. Stephen Ellis
Shadow Minister of Health (44th Parliament)
Conservative Party of Canada
House of Commons
Ottawa, Ontario
K1A 0A6
Canada
Dear Dr. Ellis,
Thank you for the response provided by your office and for expressing a willingness to assist with this urgent matter. I am writing to bring forward critical new medical evidence concerning Morgellons disease — a condition that remains unmanaged and unresolved at the federal level, despite affecting a growing number of Canadians since the global outbreak in the early 2000s. This evidence, now publicly available at morgellonsunited.com/research, was not available when the government last publicly assessed the issue. I respectfully request that it be reviewed in light of that prior undetermined position, so that appropriate procedural steps can now be taken by the Public Health Agency of Canada (PHAC) in accordance with its mandate.
In August 2009, the Federal Minister of Health acknowledged reports of Morgellons disease in Canada and internationally. That correspondence indicated that the available evidence was "extremely limited" and affirmed that PHAC was investigating the matter. The government's position was conditional — based not on a conclusive finding, but on the lack of available evidence. Since then, a substantial body of scientific and clinical data has emerged that now compels reassessment.
Specifically, numerous peer-reviewed studies now show that Morgellons disease is characterized by the presence of dermal fibers that are not environmental contaminants. These fibers, when analyzed in laboratory conditions, consistently test positive for human structural proteins — keratin and collagen — indicating they are endogenously produced and emerge from infected tissue. This finding is critical because it establishes an objective, verifiable biological marker that clearly distinguishes Morgellons from psychiatric conditions, placing it squarely within the domain of physical pathology.
It is now undeniable that the CDC’s 2012 Morgellons investigation — still cited as the foundational basis by governments and institutions to justify denial, neglect, and psychiatric mislabeling — was scientifically invalid. Dr. Randy Wymore of Oklahoma State University’s Center for the Investigation of Morgellons Disease, who served as the CDC study’s official peer reviewer, has repeatedly testified on record that fiber samples were taken from only 12 test subjects — none of whom actually had Morgellons disease. The CDC’s conclusions were flawed from inception and cannot lawfully or ethically be used to deny patients medical care or recognition.
Continued reliance on this discredited study has enabled widespread harm, systemic gaslighting, and prolonged suffering — including numerous unnecessary deaths by suicide. A curated collection of peer-reviewed studies, laboratory results, and supporting literature is now publicly available on the Morgellons United human rights organization website for review.
Because the government’s prior position was explicitly based on insufficient evidence, the emergence of credible, peer-reviewed research re-engages the legal duty to review. Under Canadian administrative law, decision-makers are required to revisit prior conclusions when materially relevant facts change. This obligation is grounded in reasonableness, procedure, fairness, and impartiality — and demands a renewed, evidence-based response.
Accordingly, I request that you review the attached draft letter — respectfully prepared in your name and subject to your discretion — addressed to the Federal Minister of Health. It calls on the Minister to direct PHAC to reopen its investigation into Morgellons disease, consistent with the agency’s duty to reassess public health matters when credible new evidence materially alters the factual landscape.
While these new studies have already established Morgellons as a legitimate physical disease based on human-derived skin fibers, this request does not presume any specific outcome. It calls for a renewed, evidence-based investigation by PHAC, grounded in current science — and independent of flawed U.S. CDC precedent.
This is entirely consistent with the government’s stated 2009 position, which expressly left room for reassessment if new evidence emerged. A renewed, good faith evaluation is not only justified — it is legally and ethically required. This is what all Canadians deserve without discrimination.
To underscore how pivotal your role is at this stage, I want you to know that, prior to my meeting with Mr. Poilievre, I spent years pursuing meaningful engagements with the Liberal Party, the New Democratic Party, and the Green Party, including direct involvement with the Prime Minister's Office and two Federal Ministers of Health under Justin Trudeau's administration, leaving me and all Canadians with commitments that resulted in no substantive outcome. I sincerely thank you for your commitment to the health, dignity, and fair treatment of all Canadians. For your reference, please see Part Two: the legal basis supporting the request to reopen the Public Health Agency of Canada investigation.
I would appreciate confirmation that this matter is under active consideration, and that this submission has been received.
Respectfully,
Lance Tycholaz
Morgellons United, Founder
Legal Basis Supporting the Request to Reopen the Public Health Agency of Canada (PHAC) Investigation
This Part Two supports the request set out in Part One. It does not allege wrongdoing or seek policy determination. It clarifies the lawful basis requiring review once new and credible medical evidence exists, and explains why failure to act constitutes a legally significant omission.
The Minister of Health exercises authority under the Department of Health Act, which establishes the Department for the purpose of preserving and improving the health of the people of Canada. Where credible evidence emerges indicating the existence of a physical disease affecting Canadians—particularly evidence not available at the time of a prior assessment—the Minister’s statutory mandate necessarily includes ensuring that such evidence is examined through appropriate public health mechanisms. Continued reliance on an evidence-limited position is not consistent with that mandate once new evidence is presented.
Matters of national public health, disease surveillance, and investigation fall within federal competence. PHAC exists for this function. The Minister of Health therefore has the authority to direct or authorize the reopening of an investigation where circumstances warrant.
In August 2009, the Office of the Federal Minister of Health acknowledged that Morgellons disease had been reported in Canada and internationally, stating that available information was limited at the time and that PHAC was engaged in investigative review. That position was expressly conditional and evidence-dependent. Where substantial new evidence is later presented, the duty to review is re-engaged.
Canada is a State Party to the International Covenant on Civil and Political Rights (ICCPR) and the Convention on the Rights of Persons with Disabilities (CRPD). Article 2 of the ICCPR obligates States to adopt measures necessary to give effect to protected rights, while the CRPD affirms the right of persons with disabilities to equal recognition, non-discrimination, and access to appropriate health services. In the public health context, reopening an investigation in response to credible medical evidence is a proportionate procedural duty. Continued refusal to review such evidence constitutes an omission by an Organ of the State once the evidentiary basis has materially changed.
Under Article 27 of the Vienna Convention on the Law of Treaties, a State may not invoke internal law, administrative practice, or prior assessments as justification for failing to perform treaty obligations. Assessments formed in the absence of current evidence cannot lawfully justify refusal to review materially changed circumstances.
The request in Part One seeks only the reopening of an investigative process by the competent authority. Part Two clarifies that refusal to review new and credible medical evidence places the Ministry in continued omission where a duty to act has been clearly re-engaged. The issue at this stage is not outcome, but lawful process.
Public Update Notice:
We will provide updates regarding any official response from the Public Health Agency of Canada or other authorities following the submission of this letter. Please check our website and social media periodically for the latest developments.
Post your message to the Comments & Questions portal found on our Morgellons United home page.
